HIKAL
Quarterly Results Analysis [Sep2025]
HIKAL Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹319 Cr | ₹380 Cr | ₹552 Cr | ₹448 Cr | ₹453 Cr | ₹407 Cr | ₹514 Cr | ₹448 Cr |
| Expenses | ₹311 Cr | ₹355 Cr | ₹429 Cr | ₹376 Cr | ₹378 Cr | ₹349 Cr | ₹420 Cr | ₹383 Cr |
| Operating Income | ₹7 Cr | ₹25 Cr | ₹123 Cr | ₹72 Cr | ₹75 Cr | ₹58 Cr | ₹94 Cr | ₹65 Cr |
| Other Income | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹4 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
| Interest | ₹15 Cr | ₹17 Cr | ₹18 Cr | ₹19 Cr | ₹19 Cr | ₹20 Cr | ₹15 Cr | ₹14 Cr |
| Depreciation | ₹41 Cr | ₹39 Cr | ₹38 Cr | ₹33 Cr | ₹32 Cr | ₹32 Cr | ₹32 Cr | ₹29 Cr |
| Profit Before Tax | ₹-47 Cr | ₹-30 Cr | ₹68 Cr | ₹24 Cr | ₹25 Cr | ₹7 Cr | ₹47 Cr | ₹22 Cr |
| Profit After Tax | ₹-35 Cr | ₹-22 Cr | ₹50 Cr | ₹17 Cr | ₹18 Cr | ₹5 Cr | ₹34 Cr | ₹16 Cr |
| EPS | ₹-2.83 | ₹-1.81 | ₹4.06 | ₹1.39 | ₹1.48 | ₹0.41 | ₹2.74 | ₹1.30 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HIKAL | -6.4% | 4.2% | -41.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.7% | 2% | -1.7% |
| DIVIS LABORATORIES | -2.1% | -2.8% | 7.8% |
| CIPLA | -1% | -1.2% | 3.6% |
| TORRENT PHARMACEUTICALS | -0.9% | -0.6% | 12.2% |
| DR REDDYS LABORATORIES | -0.1% | 2.3% | 2.6% |
| MANKIND PHARMA | -2.6% | -5.1% | -20.2% |
| ZYDUS LIFESCIENCES | -0.4% | -1.1% | -6.6% |
| LUPIN | 1.6% | 3.2% | 0.7% |
HIKAL Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -16.27 % |
| Y-o-Y | -29.68 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹319 Cr | -16.27 | |
| Jun2025 | ₹380 Cr | -31.14 | |
| Mar2025 | ₹552 Cr | 23.39 | |
| Dec2024 | ₹448 Cr | -1.15 | |
| Sep2024 | ₹453 Cr | 11.33 | |
| Jun2024 | ₹407 Cr | -20.87 | |
| Mar2024 | ₹514 Cr | 14.88 | |
| Dec2023 | ₹448 Cr | - | |
HIKAL Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -71.31 % |
| Y-o-Y | -90.39 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹7 Cr | -71.31 | |
| Jun2025 | ₹25 Cr | -79.66 | |
| Mar2025 | ₹123 Cr | 71.15 | |
| Dec2024 | ₹72 Cr | -3.74 | |
| Sep2024 | ₹75 Cr | 29.14 | |
| Jun2024 | ₹58 Cr | -38.56 | |
| Mar2024 | ₹94 Cr | 45.90 | |
| Dec2023 | ₹65 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -65.76 % |
| Y-o-Y | -86.34 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 2.26% | -65.76 | |
| Jun2025 | 6.6% | -70.46 | |
| Mar2025 | 22.34% | 38.76 | |
| Dec2024 | 16.1% | -2.66 | |
| Sep2024 | 16.54% | 15.99 | |
| Jun2024 | 14.26% | -22.33 | |
| Mar2024 | 18.36% | 26.97 | |
| Dec2023 | 14.46% | - | |
HIKAL Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹-35 Cr | Negative | |
| Jun2025 | ₹-22 Cr | Negative | |
| Mar2025 | ₹50 Cr | 191.86 | |
| Dec2024 | ₹17 Cr | -6.01 | |
| Sep2024 | ₹18 Cr | 258.82 | |
| Jun2024 | ₹5 Cr | -84.96 | |
| Mar2024 | ₹34 Cr | 110.56 | |
| Dec2023 | ₹16 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | -10.96 % | Negative | |
| Jun2025 | -5.89 % | Negative | |
| Mar2025 | 9.09 % | 136.72 | |
| Dec2024 | 3.84 % | -4.95 | |
| Sep2024 | 4.04 % | 223.20 | |
| Jun2024 | 1.25 % | -81.03 | |
| Mar2024 | 6.59 % | 83.06 | |
| Dec2023 | 3.6 % | - | |
HIKAL Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹-2.83 | Negative | |
| Jun2025 | ₹-1.81 | Negative | |
| Mar2025 | ₹4.06 | 192.09 | |
| Dec2024 | ₹1.39 | -6.08 | |
| Sep2024 | ₹1.48 | 260.98 | |
| Jun2024 | ₹0.41 | -85.04 | |
| Mar2024 | ₹2.74 | 110.77 | |
| Dec2023 | ₹1.3 | - | |
You may also like the below Video Courses